149 related articles for article (PubMed ID: 31571107)
1. Evaluation of the CRISPR/Cas9 directed mutant TP53 gene repairing effect in human prostate cancer cell line PC-3.
Batır MB; Şahin E; Çam FS
Mol Biol Rep; 2019 Dec; 46(6):6471-6484. PubMed ID: 31571107
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-mediated homology-directed repair by ssODNs in zebrafish induces complex mutational patterns resulting from genomic integration of repair-template fragments.
Boel A; De Saffel H; Steyaert W; Callewaert B; De Paepe A; Coucke PJ; Willaert A
Dis Model Mech; 2018 Oct; 11(10):. PubMed ID: 30355591
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of single-stranded DNA donors to generate conditional null mouse alleles.
Lanza DG; Gaspero A; Lorenzo I; Liao L; Zheng P; Wang Y; Deng Y; Cheng C; Zhang C; Seavitt JR; DeMayo FJ; Xu J; Dickinson ME; Beaudet AL; Heaney JD
BMC Biol; 2018 Jun; 16(1):69. PubMed ID: 29925370
[TBL] [Abstract][Full Text] [Related]
4. Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance.
Bowden AR; Morales-Juarez DA; Sczaniecka-Clift M; Agudo MM; Lukashchuk N; Thomas JC; Jackson SP
Elife; 2020 May; 9():. PubMed ID: 32441252
[TBL] [Abstract][Full Text] [Related]
5. Systematic evaluation of CRISPR-Cas systems reveals design principles for genome editing in human cells.
Wang Y; Liu KI; Sutrisnoh NB; Srinivasan H; Zhang J; Li J; Zhang F; Lalith CRJ; Xing H; Shanmugam R; Foo JN; Yeo HT; Ooi KH; Bleckwehl T; Par YYR; Lee SM; Ismail NNB; Sanwari NAB; Lee STV; Lew J; Tan MH
Genome Biol; 2018 May; 19(1):62. PubMed ID: 29843790
[TBL] [Abstract][Full Text] [Related]
6. Efficient Generation of Gene-Modified Pigs Harboring Precise Orthologous Human Mutation via CRISPR/Cas9-Induced Homology-Directed Repair in Zygotes.
Zhou X; Wang L; Du Y; Xie F; Li L; Liu Y; Liu C; Wang S; Zhang S; Huang X; Wang Y; Wei H
Hum Mutat; 2016 Jan; 37(1):110-8. PubMed ID: 26442986
[TBL] [Abstract][Full Text] [Related]
7. Optimized design parameters for CRISPR Cas9 and Cas12a homology-directed repair.
Schubert MS; Thommandru B; Woodley J; Turk R; Yan S; Kurgan G; McNeill MS; Rettig GR
Sci Rep; 2021 Sep; 11(1):19482. PubMed ID: 34593942
[TBL] [Abstract][Full Text] [Related]
8. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Editing of the
Mirgayazova R; Khadiullina R; Chasov V; Mingaleeva R; Miftakhova R; Rizvanov A; Bulatov E
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32630614
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Gene Editing Activity Directed by Single-Stranded Oligonucleotides and CRISPR/Cas9 Systems.
Bialk P; Rivera-Torres N; Strouse B; Kmiec EB
PLoS One; 2015; 10(6):e0129308. PubMed ID: 26053390
[TBL] [Abstract][Full Text] [Related]
11. Highly efficient genome editing by homology-directed repair using Cas9 protein in Ceratitis capitata.
Aumann RA; Schetelig MF; Häcker I
Insect Biochem Mol Biol; 2018 Oct; 101():85-93. PubMed ID: 30157456
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 treatment causes extended TP53-dependent cell cycle arrest in human cells.
Geisinger JM; Stearns T
Nucleic Acids Res; 2020 Sep; 48(16):9067-9081. PubMed ID: 32687165
[TBL] [Abstract][Full Text] [Related]
13. Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides.
Rivera-Torres N; Banas K; Bialk P; Bloh KM; Kmiec EB
PLoS One; 2017; 12(1):e0169350. PubMed ID: 28052104
[TBL] [Abstract][Full Text] [Related]
14. Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer.
Nientiedt C; Budczies J; Endris V; Kirchner M; Schwab C; Jurcic C; Behnisch R; Hoveida S; Lantwin P; Kaczorowski A; Geisler C; Dieffenbacher S; Falkenbach F; Franke D; Görtz M; Heller M; Himmelsbach R; Pecqueux C; Rath M; Reimold P; Schütz V; Simunovic I; Walter E; Hofer L; Gasch C; Schönberg G; Pursche L; Hatiboglu G; Nyarangi-Dix J; Sültmann H; Zschäbitz S; Koerber SA; Jäger D; Debus J; Duensing A; Schirmacher P; Hohenfellner M; Stenzinger A; Duensing S
Urol Oncol; 2022 Jan; 40(1):8.e11-8.e18. PubMed ID: 34325986
[TBL] [Abstract][Full Text] [Related]
15. Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein.
Kagita A; Lung MSY; Xu H; Kita Y; Sasakawa N; Iguchi T; Ono M; Wang XH; Gee P; Hotta A
Stem Cell Reports; 2021 Apr; 16(4):985-996. PubMed ID: 33711268
[TBL] [Abstract][Full Text] [Related]
16. CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.
Ye R; Pi M; Cox JV; Nishimoto SK; Quarles LD
J Exp Clin Cancer Res; 2017 Jun; 36(1):90. PubMed ID: 28659174
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.
Cullot G; Boutin J; Toutain J; Prat F; Pennamen P; Rooryck C; Teichmann M; Rousseau E; Lamrissi-Garcia I; Guyonnet-Duperat V; Bibeyran A; Lalanne M; Prouzet-Mauléon V; Turcq B; Ged C; Blouin JM; Richard E; Dabernat S; Moreau-Gaudry F; Bedel A
Nat Commun; 2019 Mar; 10(1):1136. PubMed ID: 30850590
[TBL] [Abstract][Full Text] [Related]
18. Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 Nickases.
Kocher T; Peking P; Klausegger A; Murauer EM; Hofbauer JP; Wally V; Lettner T; Hainzl S; Ablinger M; Bauer JW; Reichelt J; Koller U
Mol Ther; 2017 Nov; 25(11):2585-2598. PubMed ID: 28888469
[TBL] [Abstract][Full Text] [Related]
19. Systematic analysis of factors that improve homologous direct repair (HDR) efficiency in CRISPR/Cas9 technique.
Di Stazio M; Foschi N; Athanasakis E; Gasparini P; d'Adamo AP
PLoS One; 2021; 16(3):e0247603. PubMed ID: 33667229
[TBL] [Abstract][Full Text] [Related]
20. Improving Precise Genome Editing Using Donor DNA/gRNA Hybrid Duplex Generated by Complementary Bases.
Aiba W; Amai T; Ueda M; Kuroda K
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
